Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Background

Mobile health interventions showcase effectiveness for improving treatment adherence among Latent TB Infection (LTBI) patients. However, there is a paucity of evidence regarding their acceptability and usability. This study aimed to assess the initial acceptability and usability of a mobile health application that has been designed to ensure treatment adherence in LTBI patients.

Methods

A descriptive study was conducted to assess the acceptability and usability of a mobile health application, “My Treatment Friend”. A total of 82 LTBI patients were selected, and access to the application was given to them. This application provides support to LTBI patients in reporting daily medication and side effects. The basic demographic characteristics of the participants were collected through a Google form-based questionnaire. The acceptability and usability of the application were assessed using the likert scale questionnaire and SUS tool, with samples of n=44 and n=20 participants, respectively.

Results

LTBI patients found the mobile application acceptable and feasible, with an SUS score of 73, which comes under Grade B as per the SUS score sheet. The majority believed that the app was very simple to use and easy to understand. However, there is a requirement to add more features that can enhance the acceptability and usability of the application.

Conclusion

The study showed the importance and usefulness of mobile applications to assist LTBI patients in finishing their prescribed treatment courses of action. Additionally, it highlights how crucial it is to build future applications using user-centered design. User-centered design may play an important role in designing mobile applications and ensuring effective engagement and satisfaction among users.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882344154241016103856
2024-10-18
2025-01-31
Loading full text...

Full text loading...

/deliver/fulltext/nemj/5/1/NEMJ-5-E02506882344154.html?itemId=/content/journals/nemj/10.2174/0102506882344154241016103856&mimeType=html&fmt=ahah

References

  1. HoubenR.M.G.J. DoddP.J. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling.PLoS Med.20161310e100215210.1371/journal.pmed.100215227780211
    [Google Scholar]
  2. World Health OrganisationGlobal tuberculosis report 2019.2019Available from: https://iris.who.int/bitstream/handle/10665/329368/9 789241565714-eng.pdf
  3. The Secretariat, World Health OrganisationGlobal strategy and targets for tuberculosis prevention, care and control after 2015.2013Available from: https://apps.who.int/gb/ebwha/pdf_files/EB134 /B134_R4-en.pdf
  4. World Health OrganisationTowards TB elimination: An action framework for low-incidence countries.2014Available from: http://library.health.go.ug/file-download/download/public/453
  5. Centres for Disease Control and PreventionDivision of tuberculosis elimination strategic plan 2016-2020.Available from: https://www. cdc.gov/tb/about/strategicplan.htm
  6. Centres for Disease Control and PreventionTreatment of latent TB infection and TB disease.2019Available from: https://ww w.cdc.gov/tb/media/pdfs/Self_Study_Module_4_Treatment_of_Latent_TB_Infection_and_TB_Disease.pdf
  7. StaggH.R. FlookM. MartineczA. KielmannK. Abel Zur WieschP. KaratA.S. LipmanM.C.I. SloanD.J. WalkerE.F. FieldingK.L. All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era.ERJ Open Res.20206400315-202010.1183/23120541.00315‑202033263043
    [Google Scholar]
  8. World Health OrganisationDigital health for the end TB strategy - An agenda for action.2015Available from: https://www.who.int/ tb/publications/digitalhealth-TB-agenda/en/
  9. FalzonD. TimimiH. KurosinskiP. MiglioriG.B. Van GemertW. DenkingerC. IsaacsC. StoryA. GarfeinR.S. do Valle BastosL.G. YassinM.A. RusovichV. SkrahinaA. Van HoiL. BrogerT. AbubakarI. HaywardA. ThomasB.V. TemesgenZ. QuraishiS. von DelftD. JaramilloE. WeyerK. RaviglioneM.C. Digital health for the end TB strategy: Developing priority products and making them work.Eur. Respir. J.2016481294510.1183/13993003.00424‑201627230443
    [Google Scholar]
  10. BrookeJ. A quick and dirty usability scale.Available from: https://digital.ahrq.gov/sites/default/files/docs/survey/systemusabilityscale%2528sus%2529_comp%255B1%255D.pdf
  11. NaraghiS. MutsvangwaT. GoliathR. RangakaM.X. DouglasT.S. Mobile phone-based evaluation of latent tuberculosis infection: Proof of concept for an integrated image capture and analysis system.Comput. Biol. Med.201898768410.1016/j.compbiomed.2018.05.00929775913
    [Google Scholar]
  12. ChenS.H. WangI. HsuH.L. HuangC.C. LiuY.J. PutriD.U. LeeC.H. Advantage in privacy protection by using synchronous video observed treatment enhances treatment adherence among patients with latent tuberculosis infection.J. Infect. Public Health20201391354135910.1016/j.jiph.2020.03.01332376234
    [Google Scholar]
  13. NgwatuB.K. NsengiyumvaN.P. OxladeO. Mappin-KasirerB. NguyenN.L. JaramilloE. FalzonD. SchwartzmanK. The impact of digital health technologies on tuberculosis treatment: A systematic review.Eur. Respir. J.2018511170159610.1183/13993003.01596‑201729326332
    [Google Scholar]
  14. World Health OrganisationHandbook for the use of digital technologies to support tuberculosis medication adherence.World Health Organisation2018Available from: https://www.who.int/publications/i/item/9789241513456
    [Google Scholar]
  15. LamC.K. McGinnis PiloteK. HaqueA. BurzynskiJ. ChuckC. MacaraigM. Using video technology to increase treatment completion for patients with latent tuberculosis infection on 3-month isoniazid and rifapentine: An implementation study.J. Med. Internet Res.20182011e28710.2196/jmir.982530459146
    [Google Scholar]
  16. SinghalM. SinhaA.P. JoshiA. SethiyaN.K. KumarB. A mixed research study on the users-centered m-health mobile application design, development, and Sus evaluation on utility and usability for self-care management of type-2 diabetes in urban home settings.J. Popul. Ther. Clin. Pharmacol.2023301657658510.53555/jptcp.v30i16.2484
    [Google Scholar]
  17. SinhaA.P. SinghalM. JoshiA. KumarB. SethiyaN.K. User-centered “Swayam Diabetes” m-Health application for self-care management of Type 2 diabetes in urban home settings, the usability and utility testing of mobile application and perspectives.Int J Sci Res2023245141146
    [Google Scholar]
  18. LeeY. RaviglioneM.C. FlahaultA. Use of digital technology to enhance Tuberculosis control: Scoping review.J. Med. Internet Res.2020222e1572710.2196/1572732053111
    [Google Scholar]
  19. JohnstonJ.C. van der KopM.L. SmillieK. OgilvieG. MarraF. SadatsafaviM. RomanowskiK. BuddM.A. HajekJ. CookV. LesterR.T. The effect of text messaging on latent tuberculosis treatment adherence: A randomised controlled trial.Eur. Respir. J.2018512170148810.1183/13993003.01488‑201729437940
    [Google Scholar]
  20. SempleJ.L. ArmstrongK.A. Mobile applications for postoperative monitoring after discharge.CMAJ20171891E22E2410.1503/cmaj.16019527920015
    [Google Scholar]
/content/journals/nemj/10.2174/0102506882344154241016103856
Loading
/content/journals/nemj/10.2174/0102506882344154241016103856
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test